Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaffa R Rubinstein

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Contemporary Clinical Trials|March 24, 2015
NIH/NCATS/GRDR® Common Data Elements: A leading force for standardized data collectionYaffa R Rubinstein, Pamela McInnes
Contemporary Clinical Trials|July 7, 2010
Driving interest in consolidating resources for the creation of a global rare disease patient registryYaffa R Rubinstein, Stephen C Groft
Contemporary Clinical Trials|November 1, 2011
Informed consent and patient registry for the rare disease community: EditorialChristine Grady, Yaffa R Rubinstein, Stephen C Groft
Advances in Experimental Medicine and Biology|December 8, 2017
Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNERYaffa R Rubinstein, Manuel Posada de la Paz, Marina Mora
Advances in Experimental Medicine and Biology|December 8, 2017
Data Quality in Rare Diseases RegistriesYllka Kodra, Manuel Posada de la Paz, Alessio Coi, et al.
The FEBS Journal|November 11, 2005
Chromosomal protein HMGN1 modulates the expression of N-cadherinYaffa R Rubinstein, Takashi Furusawa, Jae-Hwan Lim, et al.
Contemporary Clinical Trials|November 1, 2011
Informed consent process for patient participation in rare disease registries linked to biorepositoriesYaffa R Rubinstein, Stephen C Groft, Sara Hull Chandros, et al.
Contemporary Clinical Trials|July 9, 2010
Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB)Yaffa R Rubinstein, Stephen C Groft, Ronald Bartek, et al.
JAMIA Open|January 11, 2021
The case for open science: rare diseasesYaffa R Rubinstein, Peter N Robinson, William A Gahl, et al.
International Journal of Environmental Research and Public Health|August 8, 2018
Recommendations for Improving the Quality of Rare Disease RegistriesYllka Kodra, Jérôme Weinbach, Manuel Posada-de-la-Paz, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Contemporary Clinical Trials|March 24, 2015
NIH/NCATS/GRDR® Common Data Elements: A leading force for standardized data collectionYaffa R Rubinstein, Pamela McInnes
Contemporary Clinical Trials|July 7, 2010
Driving interest in consolidating resources for the creation of a global rare disease patient registryYaffa R Rubinstein, Stephen C Groft
Contemporary Clinical Trials|November 1, 2011
Informed consent and patient registry for the rare disease community: EditorialChristine Grady, Yaffa R Rubinstein, Stephen C Groft
Advances in Experimental Medicine and Biology|December 8, 2017
Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNERYaffa R Rubinstein, Manuel Posada de la Paz, Marina Mora
Advances in Experimental Medicine and Biology|December 8, 2017
Data Quality in Rare Diseases RegistriesYllka Kodra, Manuel Posada de la Paz, Alessio Coi, et al.
The FEBS Journal|November 11, 2005
Chromosomal protein HMGN1 modulates the expression of N-cadherinYaffa R Rubinstein, Takashi Furusawa, Jae-Hwan Lim, et al.
Contemporary Clinical Trials|November 1, 2011
Informed consent process for patient participation in rare disease registries linked to biorepositoriesYaffa R Rubinstein, Stephen C Groft, Sara Hull Chandros, et al.
Contemporary Clinical Trials|July 9, 2010
Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB)Yaffa R Rubinstein, Stephen C Groft, Ronald Bartek, et al.
JAMIA Open|January 11, 2021
The case for open science: rare diseasesYaffa R Rubinstein, Peter N Robinson, William A Gahl, et al.
International Journal of Environmental Research and Public Health|August 8, 2018
Recommendations for Improving the Quality of Rare Disease RegistriesYllka Kodra, Jérôme Weinbach, Manuel Posada-de-la-Paz, et al.
Pageof 1